Drug Maker Pfizer

NY 2018 Independent Pharmacies

DOJ False Claims Act Anti Kickback

Penalty

$23.9 million

Outcome

Drug Maker Pfizer Agrees to Pay $23.85 Million to Resolve False Claims Act Liability for Paying Kickbacks

Details

Drug Maker Pfizer — DOJ Enforcement (2018)

DOJ took enforcement action against Drug Maker Pfizer in NY in 2018 involving false claims act, anti kickback violations in the Independent Pharmacies sector.

Penalty: $23.9 million

Violation types: False Claims Act, Anti Kickback
Entity type: Pharmacy
Penalty type: Settlement
Location: NY

Source: DOJ Press Release — Drug Maker Pfizer Agrees to Pay $23.85 Million to Resolve False Claims Act Liability for Paying Kickbacks

How Crucible Prevents This

Crucible's billing compliance controls enforce documentation-to-claims reconciliation and flag billing anomalies before false claims are submitted. Crucible monitors referral patterns and financial arrangements to flag potential anti-kickback violations.

Source: DOJ Press Release — Drug Maker Pfizer Agrees to Pay $23.85 Million to Resolve False Claims Act Liability for Paying Kickbacks

Don't let this happen to your organization. See how Crucible works.

See How Crucible Works